Page 45 - Rob Wright News Today : Breaking News, Live Updates & Top Stories | Vimarsana

What Went Right In 2020? My Top 5 List Source: Life Science Leader Follow Me On Twitter @RfwrightLSL “I can’t wait for 2020 to be over.” That comment was made to me over the phone late this summer, and it’s fairly easy to understand why someone would hold such sentiment. But as we officially wind down a year unlike any and all others, rather than revisit all that went wrong, let’s take a brief look at what went right. Because despite 2020 being a year many might want to forget, so much was learned that best not be forgotten. 5 – Democracy Works

Year in review: A look at news events in December 2020 The first Pfizer-BioNTech COVID-19 vaccine dose in Canada sits ready for use at The Michener Institute in Toronto on December 14, 2020. THE CANADIAN PRESS/Frank Gunn December 31, 2020 - 11:30 AM A look at news events in December 2020: 01 - U.S. President Donald Trump's science adviser announced he is leaving his post. Dr. Scott Atlas, who had no formal experience in public health or infectious diseases, gained infamy for his skepticism of measures to control the coronavirus outbreak. Atlas joined the White ...

4 Biopharma Finance Execs Tackle Tough R&D Topics Source: Life Science Leader Follow Me On Twitter @RfwrightLSL It was 2015 when Life Science Leader put together its first annual outlook issue (published in December). However, it wasn’t until 2018 that we added an article involving finance experts. That year we had just one biopharma CFO (out of four total participants) take part. This year we had 10 finance experts, with 8 being biopharmaceutical company CFOs. We are excited about this, as CFOs play a key role in so many different biopharmaceutical company components, including R&D. Unfor...

A Behind The Scenes Peek Into Oyster Point Pharma's CEO, Jeffrey Nau Source: Life Science Leader Follow Me On Twitter @RfwrightLSL Jeffrey Nau, Ph.D., president and CEO, Oyster Point Pharma. When I sat down to interview Jeffrey Nau, Ph.D., president and CEO of Oyster Point Pharma, I asked him how he became fascinated with the human eye. “Did your parents work in the medical field?” I asked. “No,” he replied. Nau then informed me that neither of his parents had graduated from college, and that he was the first person, even in his extended family, to do so. He then mentioned that when h...

7 Biopharma CEOs On Who And What To Pay Attention To In 2021 And Beyond Source: Life Science Leader Follow Me On Twitter @RfwrightLSL When you make the decision to involve 15 biopharmaceutical industry CEOs in an article for the annual outlook issue, you risk having way more content than can possibly be wedged into the printed article. Thank goodness Life Science Leader developed the online-exclusive Beyond The Printed Page section of the magazine. For this installment, we have six biopharmaceutical company CEOs providing their perspectives on companies, people, trends, and technologies they...